Shire Snaps Up Rights to a Preclinical Autoimmune Candidate for Undisclosed Sum
Rare disease giant Shire plunked down an undisclosed sum to get its hands on a preclinical autoimmune drug candidate being developed by AB Biosciences.
Source: BioSpace
Rare disease giant Shire plunked down an undisclosed sum to get its hands on a preclinical autoimmune drug candidate being developed by AB Biosciences.
Source: BioSpace